Gyros AB Quality Management System Receives ISO 9001:2008 Certification
News Dec 18, 2012
Gyros AB has announced that its quality management system has received ISO 9001:2008 certification.
The certification offers further reassurance to customers using the Gyros nanoliter-scale immunoassay platform that the products and services they receive are of a consistently high standard.
The Gyros platform is used by major biopharmaceutical companies and their service providers worldwide to improve productivity and efficiency during the development of biotherapeutics and vaccines, boosting time-critical workflows and helping to meet regulatory demands.
The quality management system was ISO 9001:2008 certified by Svensk Certifiering Norden.
Erik Walldén, CEO at Gyros, commented: “At Gyros we have developed our Quality Management System over many years in order to establish well-functioning operating procedures for all parts of the company. Becoming ISO 9001 registered enables customers to feel even more confident in our products and services, as this is a confirmation that we follow internationally accepted standards for quality management.”
Cobra Biologics Awarded £2.6m ($3.4m USD) from Innovate UKNews
Capital infrastructure investment to embed and secure clinical and commercial viral vector manufacturing capability within the UK. Award made as part of UK’s Innovation Agency’s Industrial Strategy boost for UK medicines with £70m of funding to help develop new treatments.READ MORE
‘Long Acting’ Nanomedicine for the Prevention Of MalariaNews
A new study, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.READ MORE